PRDM1 and acute myeloid leukemia: Loss of Blimp-1 indicates poor prognosis in B-cell-like diffuse large B-cell lymphoma (Xia et al. 2017), whereas Zhu et al. (2017) showed that Blimp-1 inhibited the T cell response in acute myeloid leukemia.